Report overview
This report contains market size and forecasts of Antiepileptic Drugs in global, including the following market information:
Global Antiepileptic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antiepileptic Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Antiepileptic Drugs companies in 2021 (%)
The global Antiepileptic Drugs market was valued at 4099.5 million in 2021 and is projected to reach US$ 4729.1 million by 2028, at a CAGR of 2.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiepileptic Drugs include Abbott Laboratories, Cephalon, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi, UCB Pharma, GlaxoSmithKline, Johnson & Johnson and Novartis and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiepileptic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiepileptic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Antiepileptic Drugs Market Segment Percentages, by Type, 2021 (%)
First Generation
Second Generation
Global Antiepileptic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Antiepileptic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Global Antiepileptic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Antiepileptic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiepileptic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antiepileptic Drugs revenues share in global market, 2021 (%)
Key companies Antiepileptic Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Antiepileptic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Cephalon
Sunovion Pharmaceuticals
Valeant Pharmaceuticals International
Sanofi
UCB Pharma
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
